The biological basis of severe outcomes in Anaplasma phagocytophilum infection.
about
Tick-Host-Pathogen Interactions: Conflict and CooperationAnaplasma phagocytophilum: deceptively simple or simply deceptive?The role of CD8 T lymphocytes in rickettsial infectionsAn O-Methyltransferase Is Required for Infection of Tick Cells by Anaplasma phagocytophilumThe Prostaglandin E2-EP3 Receptor Axis Regulates Anaplasma phagocytophilum-Mediated NLRC4 Inflammasome ActivationPro-inflammatory immune responses are associated with clinical signs and symptoms of human anaplasmosis.The tick salivary protein sialostatin L2 inhibits caspase-1-mediated inflammation during Anaplasma phagocytophilum infection.Prevalence and genetic variability of Anaplasma phagocytophilum in wild rodents from the Italian alps.Interferon-γ-dependent control of Anaplasma phagocytophilum by murine neutrophil granulocytes.Anaplasma phagocytophilum dihydrolipoamide dehydrogenase 1 affects host-derived immunopathology during microbial colonization.Stat1 negatively regulates immune-mediated injury with Anaplasma phagocytophilum infection.Matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid identification of tick vectorsMolecular analysis of Anaplasma phagocytophilum isolated from patients with febrile diseases of unknown etiology in ChinaDiagnosis of human granulocytic anaplasmosis in Belgium by combining molecular and serological methodsMolecular characterization of Msp2/P44 of Anaplasma phagocytophilum isolated from infected patients and Haemaphysalis longicornis in Laizhou Bay, Shandong Province, ChinaAnaplasma phagocytophilum--a widespread multi-host pathogen with highly adaptive strategies.Prevalence of Anaplasma, Bartonella and Borrelia Species in Haemaphysalis longicornis collected from goats in North Korea.Genome-Wide Anaplasma phagocytophilum AnkA-DNA Interactions Are Enriched in Intergenic Regions and Gene Promoters and Correlate with Infection-Induced Differential Gene Expression.Engineering of obligate intracellular bacteria: progress, challenges and paradigms.Influence of Genetic Background on Hematologic and Histopathologic Alterations during Acute Granulocytic Anaplasmosis in 129/SvEv and C57BL/6J Mice Lacking Type I and Type II Interferon Signaling.A novel high-resolution melt PCR assay discriminates Anaplasma phagocytophilum and "Candidatus Neoehrlichia mikurensis".Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.Anaplasma phagocytophilum-Occupied Vacuole Interactions with the Host Cell Cytoskeleton.Alternative Splicing of Differentiated Myeloid Cell Transcripts after Infection by Anaplasma phagocytophilum Impacts a Selective Group of Cellular Programs.Severe Human Granulocytic Anaplasmosis With Significantly Elevated Ferritin Levels in an Immunocompetent Host in Pennsylvania: A Case Report.Anaplasma phagocytophilum-Related Defects in CD8, NKT, and NK Lymphocyte Cytotoxicity.
P2860
Q26751248-FC974D11-8F29-47E7-A10A-3DBECC15EE92Q27006742-01ACF3CB-9CD7-4769-BAD7-0380626CA664Q27008840-5E195DDF-D8D5-485C-83B9-CDFB56A51142Q28550741-C31A78E4-091F-4AA9-9238-21A592EFDE36Q28553346-EAB13828-00DC-4B9B-A7AE-E29362C4869FQ33442815-9E08222A-759E-4560-B512-4BE897BB256FQ33603072-6AA60CA0-86A6-4AAD-BAA1-C1764C4E6371Q33801420-EB762292-6D9B-4494-9111-E7176D6EBCA0Q33896496-1B764008-B40C-43B1-917A-DC3AAB3980BAQ34323818-5C2B2886-CEC0-476D-B4D5-8964978360DBQ34476289-4DC8B691-E909-4CBA-ABA4-E8A4496F63ACQ34504419-24F50B7B-BCD4-4F6E-B5D8-193410E81236Q34603114-DDE76CFA-EEFA-4BC5-96EB-58FE5B2415E0Q34692018-0319CFD8-2093-4EA8-BA69-C40799164D90Q35027862-EF07A0E1-60A8-4E78-99BA-0DB3DD8B1765Q37030096-7FCF34F5-D391-4DE7-B669-4A7270B8B211Q37039491-DDDEAB70-6BC6-45D5-A864-7D5C0C6F11DAQ37266240-88292ED6-E09B-496B-BF15-45074ECD102EQ37833951-8FFDF937-EE65-4AB4-A966-92667A989102Q38734461-E01B9D3E-A8A8-4FA1-8780-425C0BCBE823Q39149493-A477D429-4642-439B-998C-CD8B84AF05E1Q40044232-1440F6BC-480B-4511-AE0F-EA85EEED3B07Q43378658-2E7DF848-3115-407A-AC9C-37AF6DC15CC6Q49866214-8FCD69BA-ECCA-4612-97AD-0A3B68E21939Q50280974-56A503F4-03E0-4675-A37B-1273B24F7496Q55288424-88C082F5-60C1-4075-B1EF-66CFD3F53104
P2860
The biological basis of severe outcomes in Anaplasma phagocytophilum infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The biological basis of severe outcomes in Anaplasma phagocytophilum infection.
@ast
The biological basis of severe outcomes in Anaplasma phagocytophilum infection.
@en
type
label
The biological basis of severe outcomes in Anaplasma phagocytophilum infection.
@ast
The biological basis of severe outcomes in Anaplasma phagocytophilum infection.
@en
prefLabel
The biological basis of severe outcomes in Anaplasma phagocytophilum infection.
@ast
The biological basis of severe outcomes in Anaplasma phagocytophilum infection.
@en
P2860
P1476
The biological basis of severe outcomes in Anaplasma phagocytophilum infection.
@en
P2093
J Stephen Dumler
P2860
P356
10.1111/J.1574-695X.2011.00909.X
P577
2011-12-19T00:00:00Z